뒤로
Infant Bacterial Therapeutics AB (IFTBF) 주가 예측
IFTBF 주가 차트
IFTBF 주가 예측
Infant Bacterial Therapeutics AB
$0
0%
$0
종가: Mar 30, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: Mar 30, 17:34:51 GMT-4
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
676
배당수익률
--
EPS(TTM)
--
시가총액
--
INFANT BACTERIAL THERAPEUTICS A란 무엇인가요?
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.